PRÓBA BIOMARKEROWA APALUTAMIDU I PROMIENIOWANIA W NAWRACAJĄCYM RAKU PROSTATY
Faza II, podwójnie ślepa, kontrolowana placebo, randomizowana próba radioterapii ratunkowej z lub bez wzmocnionej terapii antyandrogenowej z apalutamidem w nawracającym raku prostaty
This phase II trial studies how well radiation therapy with or without apalutamide works in treating patients with prostate cancer that has come back (recurrent). Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgen can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may lessen the amount of androgen made by the body. Giving radiation therapy and apalutamide may work better at treating prostate cancer compared to radiation therapy alone.
Przegląd badań
Status
Status
Warunki
Warunki
Interwencja / Leczenie
Interwencja / Leczenie
Szczegółowy opis
PRIMARY OBJECTIVE:
I. To determine whether, in men with post-prostatectomy prostate-specific antigen (PSA) recurrences, salvage radiation (SRT) with enhanced anti-androgen therapy with apalutamide will improve biochemical progression-free survival (bPFS) compared to SRT alone.
SECONDARY OBJECTIVES:
I. To assess whether molecular stratification by the PAM50 gene expression clustering will identify subsets of prostate cancer (luminal A or basal, luminal B) which derive the greatest benefit from anti-androgen therapy.
II. To assess overall survival. III. To assess cancer-specific mortality. IV. To assess metastasis-free survival. V. To assess distant metastasis. VI. To assess local-regional progression. VII. To assess PSA nadir during first year of treatment and prior to initiation of any hormonal salvage therapy.
VIII. To assess initiation of salvage hormonal therapy. IX. To assess PSA with a non-castrate testosterone at 1 and 3 years post randomization: PSA < 0.1 ng/ml and testosterone >= 50 ng/dl.
X. To assess acute and late physician-reported morbidity (per the Common Terminology Criteria for Adverse Events [CTCAE] version 5.0) after SRT +/- apalutamide.
XI. To assess acute and late patient-reported symptomatic adverse events morbidity (per the patient reported outcomes [PRO]-CTCAE) after SRT +/- apalutamide.
XII. To assess testosterone levels at 3, 6, 9, 12, and 36 months post randomization.
EXPLORATORY OBJECTIVE:
I. To assess the prognostic and predictive value of the genomic classifier Decipher.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM 1: Patients undergo external beam radiation therapy on day 1 for 7-8 weeks. Beginning on day of radiation therapy, patients receive placebo orally (PO) once daily (QD) on days 1-30. Treatment repeats every 30 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity.
ARM 2: Patients undergo external beam radiation therapy on day 1 for 7-8 weeks. Beginning on day of radiation therapy, patients receive apalutamide PO QD on days 1-30. Treatment repeats every 30 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, then every 6 months for 3 years, and then yearly thereafter.
Typ studiów
Typ studiów
Zapisy (Rzeczywisty)
Zapisy
Faza
Faza
- Faza 2
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Alberta
-
Calgary, Alberta, Kanada, T2N 5G2
- Arthur J E Child Comprehensive Cancer Centre
-
-
Ontario
-
Toronto, Ontario, Kanada, M5G 2M9
- University Health Network-Princess Margaret Hospital
-
-
Quebec
-
Montreal, Quebec, Kanada, H3H 2R9
- The Research Institute of the McGill University Health Centre (MUHC)
-
Montreal, Quebec, Kanada, H1T 2M4
- CIUSSSEMTL-Hopital Maisonneuve-Rosemont
-
Québec, Quebec, Kanada, G1R 2J6
- CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
-
Sherbrooke, Quebec, Kanada, J1H 5N4
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
-
-
Saskatchewan
-
Regina, Saskatchewan, Kanada, S4T 7T1
- Allan Blair Cancer Centre
-
Saskatoon, Saskatchewan, Kanada, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
Arizona
-
Gilbert, Arizona, Stany Zjednoczone, 85297
- Arizona Center for Cancer Care - Gilbert
-
Peoria, Arizona, Stany Zjednoczone, 85381
- Arizona Center for Cancer Care-Peoria
-
Scottsdale, Arizona, Stany Zjednoczone, 85258
- Arizona Center for Cancer Care - Scottsdale
-
Surprise, Arizona, Stany Zjednoczone, 85374
- Arizona Center for Cancer Care-Surprise
-
-
Arkansas
-
Little Rock, Arkansas, Stany Zjednoczone, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Berkeley, California, Stany Zjednoczone, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Greenbrae, California, Stany Zjednoczone, 94904
- Marin General Hospital
-
Los Angeles, California, Stany Zjednoczone, 90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles, California, Stany Zjednoczone, 90048
- Cedars Sinai Medical Center
-
Los Angeles, California, Stany Zjednoczone, 90033
- Los Angeles General Medical Center
-
Roseville, California, Stany Zjednoczone, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Sacramento, California, Stany Zjednoczone, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Stany Zjednoczone, 95817
- University of California Davis Comprehensive Cancer Center
-
Truckee, California, Stany Zjednoczone, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Vallejo, California, Stany Zjednoczone, 94589
- Sutter Solano Medical Center/Cancer Center
-
-
Colorado
-
Aurora, Colorado, Stany Zjednoczone, 80045
- UCHealth University of Colorado Hospital
-
Colorado Springs, Colorado, Stany Zjednoczone, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Stany Zjednoczone, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, Stany Zjednoczone, 80920
- Memorial Hospital North
-
Fort Collins, Colorado, Stany Zjednoczone, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Stany Zjednoczone, 80528
- Cancer Care and Hematology-Fort Collins
-
Glenwood Springs, Colorado, Stany Zjednoczone, 81601
- Valley View Hospital Cancer Center
-
Greeley, Colorado, Stany Zjednoczone, 80631
- UCHealth Greeley Hospital
-
Loveland, Colorado, Stany Zjednoczone, 80538
- Medical Center of the Rockies
-
-
Connecticut
-
Stamford, Connecticut, Stany Zjednoczone, 06904
- Stamford Hospital/Bennett Cancer Center
-
-
Delaware
-
Newark, Delaware, Stany Zjednoczone, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Stany Zjednoczone, 19718
- Christiana Care Health System-Christiana Hospital
-
Rehoboth Beach, Delaware, Stany Zjednoczone, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stany Zjednoczone, 20037
- George Washington University Medical Center
-
-
Florida
-
Altamonte Springs, Florida, Stany Zjednoczone, 32701
- AdventHealth Altamonte
-
Fort Myers, Florida, Stany Zjednoczone, 33905
- Regional Cancer Center-Lee Memorial Health System
-
Kissimmee, Florida, Stany Zjednoczone, 34744
- AdventHealth Kissimmee
-
Orlando, Florida, Stany Zjednoczone, 32803
- AdventHealth Orlando
-
Orlando, Florida, Stany Zjednoczone, 32822
- AdventHealth East Orlando
-
Weston, Florida, Stany Zjednoczone, 33331
- Cleveland Clinic-Weston
-
Winter Park, Florida, Stany Zjednoczone, 32792
- AdventHealth Winter Park
-
-
Georgia
-
Atlanta, Georgia, Stany Zjednoczone, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Stany Zjednoczone, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Stany Zjednoczone, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, Stany Zjednoczone, 30303
- Grady Health System
-
Atlanta, Georgia, Stany Zjednoczone, 30342
- Northside Hospital
-
Augusta, Georgia, Stany Zjednoczone, 30912
- Augusta University Medical Center
-
Savannah, Georgia, Stany Zjednoczone, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Idaho
-
Boise, Idaho, Stany Zjednoczone, 83712
- Saint Luke's Cancer Institute - Boise
-
Fruitland, Idaho, Stany Zjednoczone, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Stany Zjednoczone, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Stany Zjednoczone, 83687
- Saint Luke's Cancer Institute - Nampa
-
Twin Falls, Idaho, Stany Zjednoczone, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Chicago, Illinois, Stany Zjednoczone, 60612
- University of Illinois
-
Chicago, Illinois, Stany Zjednoczone, 60612
- Rush MD Anderson Cancer Center
-
Decatur, Illinois, Stany Zjednoczone, 62526
- Decatur Memorial Hospital
-
Effingham, Illinois, Stany Zjednoczone, 62401
- Crossroads Cancer Center
-
Hines, Illinois, Stany Zjednoczone, 60141
- Edward Hines Jr VA Hospital
-
Maywood, Illinois, Stany Zjednoczone, 60153
- Loyola University Medical Center
-
Peoria, Illinois, Stany Zjednoczone, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Stany Zjednoczone, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Stany Zjednoczone, 61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Springfield, Illinois, Stany Zjednoczone, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Stany Zjednoczone, 62702
- Springfield Clinic
-
Springfield, Illinois, Stany Zjednoczone, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, Stany Zjednoczone, 61801
- Carle Cancer Center
-
-
Indiana
-
Fort Wayne, Indiana, Stany Zjednoczone, 46805
- Parkview Hospital Randallia
-
Fort Wayne, Indiana, Stany Zjednoczone, 46845
- Parkview Regional Medical Center
-
Goshen, Indiana, Stany Zjednoczone, 46526
- Goshen Center for Cancer Care
-
Richmond, Indiana, Stany Zjednoczone, 47374
- Reid Health
-
-
Iowa
-
Clive, Iowa, Stany Zjednoczone, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Stany Zjednoczone, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Creston, Iowa, Stany Zjednoczone, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
West Des Moines, Iowa, Stany Zjednoczone, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Kansas City, Kansas, Stany Zjednoczone, 66160
- University of Kansas Cancer Center
-
Olathe, Kansas, Stany Zjednoczone, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, Stany Zjednoczone, 66210
- University of Kansas Cancer Center-Overland Park
-
Salina, Kansas, Stany Zjednoczone, 67401
- Salina Regional Health Center
-
Westwood, Kansas, Stany Zjednoczone, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
-
Kentucky
-
Lexington, Kentucky, Stany Zjednoczone, 40536
- University of Kentucky/Markey Cancer Center
-
-
Louisiana
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70809
- Mary Bird Perkins Cancer Center
-
Metairie, Louisiana, Stany Zjednoczone, 70006
- East Jefferson General Hospital
-
Metairie, Louisiana, Stany Zjednoczone, 70006
- LSU Healthcare Network / Metairie Multi-Specialty Clinic
-
-
Maine
-
Bath, Maine, Stany Zjednoczone, 04530
- MaineHealth Coastal Cancer Treatment Center
-
Belfast, Maine, Stany Zjednoczone, 04915
- MaineHealth Waldo Hospital
-
Biddeford, Maine, Stany Zjednoczone, 04005
- MaineHealth Maine Medical Center - Biddeford
-
Brewer, Maine, Stany Zjednoczone, 04412
- Lafayette Family Cancer Center-EMMC
-
Norway, Maine, Stany Zjednoczone, 04268
- MaineHealth Stephens Hospital
-
Portland, Maine, Stany Zjednoczone, 04102
- MaineHealth Maine Medical Center - Portland
-
Rockport, Maine, Stany Zjednoczone, 04856
- Penobscot Bay Medical Center
-
Sanford, Maine, Stany Zjednoczone, 04073
- MaineHealth Cancer Care Center of York County
-
Sanford, Maine, Stany Zjednoczone, 04073
- MaineHealth Cancer Care and IV Therapy - Sanford
-
Scarborough, Maine, Stany Zjednoczone, 04074
- MaineHealth Maine Medical Center- Scarborough
-
South Portland, Maine, Stany Zjednoczone, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Baltimore, Maryland, Stany Zjednoczone, 21201
- University of Maryland/Greenebaum Cancer Center
-
Baltimore, Maryland, Stany Zjednoczone, 21229
- Saint Agnes Hospital
-
Columbia, Maryland, Stany Zjednoczone, 21044
- Central Maryland Radiation Oncology in Howard County
-
Glen Burnie, Maryland, Stany Zjednoczone, 21061
- UM Baltimore Washington Medical Center/Tate Cancer Center
-
-
Massachusetts
-
Burlington, Massachusetts, Stany Zjednoczone, 01805
- Lahey Hospital and Medical Center
-
Lowell, Massachusetts, Stany Zjednoczone, 01854
- Lowell General Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Stany Zjednoczone, 48109
- University of Michigan Rogel Cancer Center
-
Ann Arbor, Michigan, Stany Zjednoczone, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Stany Zjednoczone, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Stany Zjednoczone, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Stany Zjednoczone, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Stany Zjednoczone, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Stany Zjednoczone, 48346
- Michigan Healthcare Professionals Clarkston
-
Clinton Township, Michigan, Stany Zjednoczone, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn, Michigan, Stany Zjednoczone, 48124
- Corewell Health Dearborn Hospital
-
Detroit, Michigan, Stany Zjednoczone, 48202
- Henry Ford Hospital
-
East Lansing, Michigan, Stany Zjednoczone, 48823
- Michigan State University
-
Farmington Hills, Michigan, Stany Zjednoczone, 48334
- Michigan Healthcare Professionals Farmington
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Kalamazoo, Michigan, Stany Zjednoczone, 49007
- West Michigan Cancer Center
-
Lansing, Michigan, Stany Zjednoczone, 48912
- University of Michigan Health - Sparrow Lansing
-
Niles, Michigan, Stany Zjednoczone, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Reed City, Michigan, Stany Zjednoczone, 49677
- Corewell Health Reed City Hospital
-
Royal Oak, Michigan, Stany Zjednoczone, 48073
- Corewell Health William Beaumont University Hospital
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Traverse City, Michigan, Stany Zjednoczone, 49684
- Munson Medical Center
-
Troy, Michigan, Stany Zjednoczone, 48098
- Michigan Healthcare Professionals Troy
-
Troy, Michigan, Stany Zjednoczone, 48085
- Corewell Health Beaumont Troy Hospital
-
West Bloomfield, Michigan, Stany Zjednoczone, 48322
- Henry Ford West Bloomfield Hospital
-
Wyoming, Michigan, Stany Zjednoczone, 49519
- University of Michigan Health - West
-
-
Minnesota
-
Albert Lea, Minnesota, Stany Zjednoczone, 56007
- Mayo Clinic Health System in Albert Lea
-
Burnsville, Minnesota, Stany Zjednoczone, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Stany Zjednoczone, 55433
- Mercy Hospital
-
Edina, Minnesota, Stany Zjednoczone, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, Stany Zjednoczone, 55432
- Unity Hospital
-
Mankato, Minnesota, Stany Zjednoczone, 56001
- Mayo Clinic Health Systems-Mankato
-
Maple Grove, Minnesota, Stany Zjednoczone, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, Stany Zjednoczone, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Stany Zjednoczone, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Stany Zjednoczone, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Stany Zjednoczone, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Stany Zjednoczone, 55454
- Health Partners Inc
-
Minneapolis, Minnesota, Stany Zjednoczone, 55417
- Minneapolis VA Medical Center
-
Monticello, Minnesota, Stany Zjednoczone, 55362
- Monticello Cancer Center
-
Robbinsdale, Minnesota, Stany Zjednoczone, 55422
- North Memorial Medical Health Center
-
Rochester, Minnesota, Stany Zjednoczone, 55905
- Mayo Clinic in Rochester
-
Saint Cloud, Minnesota, Stany Zjednoczone, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Saint Louis Park, Minnesota, Stany Zjednoczone, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Stany Zjednoczone, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Stany Zjednoczone, 55102
- United Hospital
-
Shakopee, Minnesota, Stany Zjednoczone, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Stany Zjednoczone, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Stany Zjednoczone, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Stany Zjednoczone, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Stany Zjednoczone, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Wyoming, Minnesota, Stany Zjednoczone, 55092
- Fairview Lakes Medical Center
-
-
Mississippi
-
Jackson, Mississippi, Stany Zjednoczone, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Cape Girardeau, Missouri, Stany Zjednoczone, 63703
- Mercy Cancer Center - Cape Girardeau
-
City of Saint Peters, Missouri, Stany Zjednoczone, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Creve Coeur, Missouri, Stany Zjednoczone, 63141
- Siteman Cancer Center at West County Hospital
-
Jefferson City, Missouri, Stany Zjednoczone, 65109
- MU Health Care Goldschmidt Cancer Center
-
Kansas City, Missouri, Stany Zjednoczone, 64128
- Kansas City Veterans Affairs Medical Center
-
Kansas City, Missouri, Stany Zjednoczone, 64154
- University of Kansas Cancer Center - North
-
Lee's Summit, Missouri, Stany Zjednoczone, 64064
- University of Kansas Cancer Center - Lee's Summit
-
Rolla, Missouri, Stany Zjednoczone, 65401
- Phelps Health Delbert Day Cancer Institute
-
St Louis, Missouri, Stany Zjednoczone, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Stany Zjednoczone, 63129
- Siteman Cancer Center-South County
-
St Louis, Missouri, Stany Zjednoczone, 63141
- Mercy Hospital Saint Louis
-
-
Montana
-
Billings, Montana, Stany Zjednoczone, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, Stany Zjednoczone, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Stany Zjednoczone, 59405
- Benefis Sletten Cancer Institute
-
-
Nebraska
-
Omaha, Nebraska, Stany Zjednoczone, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Stany Zjednoczone, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Stany Zjednoczone, 68124
- Alegent Health Bergan Mercy Medical Center
-
-
Nevada
-
Henderson, Nevada, Stany Zjednoczone, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, Stany Zjednoczone, 89052
- OptumCare Cancer Care at Seven Hills
-
Henderson, Nevada, Stany Zjednoczone, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, Stany Zjednoczone, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, Stany Zjednoczone, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, Stany Zjednoczone, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, Stany Zjednoczone, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, Stany Zjednoczone, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Stany Zjednoczone, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Stany Zjednoczone, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, Stany Zjednoczone, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, Stany Zjednoczone, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Stany Zjednoczone, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, Stany Zjednoczone, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, Stany Zjednoczone, 89148
- OptumCare Cancer Care at Fort Apache
-
Las Vegas, Nevada, Stany Zjednoczone, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, Stany Zjednoczone, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Stany Zjednoczone, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, Stany Zjednoczone, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, Stany Zjednoczone, 89121
- Cancer Therapy and Integrative Medicine
-
Las Vegas, Nevada, Stany Zjednoczone, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, Stany Zjednoczone, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, Stany Zjednoczone, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, Stany Zjednoczone, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, Stany Zjednoczone, 89102
- Desert West Surgery
-
Las Vegas, Nevada, Stany Zjednoczone, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, Stany Zjednoczone, 89169
- University Cancer Center
-
Las Vegas, Nevada, Stany Zjednoczone, 89128
- Oncology Las Vegas - Tenaya
-
Pahrump, Nevada, Stany Zjednoczone, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, Stany Zjednoczone, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Concord, New Hampshire, Stany Zjednoczone, 03301
- New Hampshire Oncology Hematology PA-Concord
-
Lebanon, New Hampshire, Stany Zjednoczone, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, Stany Zjednoczone, 03103
- Solinsky Center for Cancer Care
-
-
New Jersey
-
Mount Holly, New Jersey, Stany Zjednoczone, 08060
- Virtua Memorial
-
New Brunswick, New Jersey, Stany Zjednoczone, 08903
- Rutgers Cancer Institute of New Jersey
-
Sewell, New Jersey, Stany Zjednoczone, 08080
- Sidney Kimmel Cancer Center Washington Township
-
Somerville, New Jersey, Stany Zjednoczone, 08876
- Robert Wood Johnson University Hospital Somerset
-
-
New Mexico
-
Albuquerque, New Mexico, Stany Zjednoczone, 87109
- New Mexico Oncology Hematology Consultants
-
Albuquerque, New Mexico, Stany Zjednoczone, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Brooklyn, New York, Stany Zjednoczone, 11215
- New York-Presbyterian/Brooklyn Methodist Hospital
-
Canandaigua, New York, Stany Zjednoczone, 14424
- Sands Cancer Center
-
Cooperstown, New York, Stany Zjednoczone, 13326
- Mary Imogene Bassett Hospital
-
New York, New York, Stany Zjednoczone, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Stany Zjednoczone, 14642
- University of Rochester
-
Rochester, New York, Stany Zjednoczone, 14620
- Highland Hospital
-
Rochester, New York, Stany Zjednoczone, 14606
- Wilmot Cancer Institute Radiation Oncology at Greece
-
Stony Brook, New York, Stany Zjednoczone, 11794
- Stony Brook University Medical Center
-
Syracuse, New York, Stany Zjednoczone, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, Stany Zjednoczone, 10468
- James J Peters VA Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, Stany Zjednoczone, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Supply, North Carolina, Stany Zjednoczone, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Wilmington, North Carolina, Stany Zjednoczone, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, Stany Zjednoczone, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
-
Ohio
-
Akron, Ohio, Stany Zjednoczone, 44307
- Cleveland Clinic Akron General
-
Akron, Ohio, Stany Zjednoczone, 44304
- Summa Health System - Akron Campus
-
Beachwood, Ohio, Stany Zjednoczone, 44122
- UHHS-Chagrin Highlands Medical Center
-
Beavercreek, Ohio, Stany Zjednoczone, 45431
- Indu and Raj Soin Medical Center
-
Centerville, Ohio, Stany Zjednoczone, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Stany Zjednoczone, 45459
- Dayton Physicians LLC-Miami Valley South
-
Chardon, Ohio, Stany Zjednoczone, 44024
- Geauga Hospital
-
Cincinnati, Ohio, Stany Zjednoczone, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cincinnati, Ohio, Stany Zjednoczone, 45236
- Oncology Hematology Care Inc-Kenwood
-
Cleveland, Ohio, Stany Zjednoczone, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Stany Zjednoczone, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Stany Zjednoczone, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Stany Zjednoczone, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Stany Zjednoczone, 43219
- The Mark H Zangmeister Center
-
Dayton, Ohio, Stany Zjednoczone, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Stany Zjednoczone, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Stany Zjednoczone, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Stany Zjednoczone, 45415
- Dayton Physician LLC - Englewood
-
Findlay, Ohio, Stany Zjednoczone, 45840
- Blanchard Valley Hospital
-
Findlay, Ohio, Stany Zjednoczone, 45840
- Armes Family Cancer Center
-
Findlay, Ohio, Stany Zjednoczone, 45840
- Orion Cancer Care
-
Franklin, Ohio, Stany Zjednoczone, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, Stany Zjednoczone, 45005
- Dayton Physicians LLC-Atrium
-
Greenville, Ohio, Stany Zjednoczone, 45331
- Wayne Hospital
-
Greenville, Ohio, Stany Zjednoczone, 45331
- Dayton Physicians LLC-Wayne
-
Kettering, Ohio, Stany Zjednoczone, 45429
- Kettering Medical Center
-
Kettering, Ohio, Stany Zjednoczone, 45409
- Greater Dayton Cancer Center
-
Kettering, Ohio, Stany Zjednoczone, 45420
- First Dayton Cancer Care
-
Mansfield, Ohio, Stany Zjednoczone, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Mayfield Heights, Ohio, Stany Zjednoczone, 44124
- Hillcrest Hospital Cancer Center
-
Mentor, Ohio, Stany Zjednoczone, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, Stany Zjednoczone, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Parma, Ohio, Stany Zjednoczone, 44129
- University Hospitals Parma Medical Center
-
Ravenna, Ohio, Stany Zjednoczone, 44266
- University Hospitals Portage Medical Center
-
Sandusky, Ohio, Stany Zjednoczone, 44870
- North Coast Cancer Care
-
Sandusky, Ohio, Stany Zjednoczone, 44870
- UH Seidman Cancer Center at Firelands Regional Medical Center
-
Springfield, Ohio, Stany Zjednoczone, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Stany Zjednoczone, 45504
- Springfield Regional Medical Center
-
Strongsville, Ohio, Stany Zjednoczone, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Troy, Ohio, Stany Zjednoczone, 45373
- Upper Valley Medical Center
-
Troy, Ohio, Stany Zjednoczone, 45373
- Dayton Physicians LLC - Troy
-
West Chester, Ohio, Stany Zjednoczone, 45069
- University of Cincinnati Cancer Center-West Chester
-
Westlake, Ohio, Stany Zjednoczone, 44145
- UHHS-Westlake Medical Center
-
Wooster, Ohio, Stany Zjednoczone, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stany Zjednoczone, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Stany Zjednoczone, 74133
- Cancer Treatment Centers of America
-
-
Oregon
-
Gresham, Oregon, Stany Zjednoczone, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, Stany Zjednoczone, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
-
Pennsylvania
-
Altoona, Pennsylvania, Stany Zjednoczone, 16601
- UPMC Altoona
-
Beaver, Pennsylvania, Stany Zjednoczone, 15009
- UPMC-Heritage Valley Health System Beaver
-
Bethlehem, Pennsylvania, Stany Zjednoczone, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Chadds Ford, Pennsylvania, Stany Zjednoczone, 19317
- Christiana Care Health System-Concord Health Center
-
Dunmore, Pennsylvania, Stany Zjednoczone, 18512
- Northeast Radiation Oncology Center
-
Farrell, Pennsylvania, Stany Zjednoczone, 16121
- UPMC Cancer Center at UPMC Horizon
-
Greensburg, Pennsylvania, Stany Zjednoczone, 15601
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Harrisburg, Pennsylvania, Stany Zjednoczone, 17109
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus
-
Hershey, Pennsylvania, Stany Zjednoczone, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Johnstown, Pennsylvania, Stany Zjednoczone, 15901
- UPMC-Johnstown/John P. Murtha Regional Cancer Center
-
McKeesport, Pennsylvania, Stany Zjednoczone, 15132
- UPMC Cancer Center at UPMC McKeesport
-
Monroeville, Pennsylvania, Stany Zjednoczone, 15146
- UPMC Cancer Center - Monroeville
-
Moon Township, Pennsylvania, Stany Zjednoczone, 15108
- UPMC Hillman Cancer Center in Coraopolis
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19114
- Jefferson Torresdale Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15213
- UPMC-Magee Womens Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15215
- UPMC-Saint Margaret
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15237
- UPMC-Passavant Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15243
- UPMC-Saint Clair Hospital Cancer Center
-
Sayre, Pennsylvania, Stany Zjednoczone, 18840
- Guthrie Medical Group PC-Robert Packer Hospital
-
Seneca, Pennsylvania, Stany Zjednoczone, 16346
- UPMC Cancer Center at UPMC Northwest
-
Uniontown, Pennsylvania, Stany Zjednoczone, 15401
- UPMC Uniontown Hospital Radiation Oncology
-
Washington, Pennsylvania, Stany Zjednoczone, 15301
- UPMC Washington Hospital Radiation Oncology
-
West Reading, Pennsylvania, Stany Zjednoczone, 19611
- Reading Hospital
-
Willow Grove, Pennsylvania, Stany Zjednoczone, 19090
- Asplundh Cancer Pavilion
-
-
South Carolina
-
Boiling Springs, South Carolina, Stany Zjednoczone, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Greenville, South Carolina, Stany Zjednoczone, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Stany Zjednoczone, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenwood, South Carolina, Stany Zjednoczone, 29646
- Self Regional Healthcare
-
Greer, South Carolina, Stany Zjednoczone, 29650
- Prisma Health Cancer Institute - Greer
-
Hilton Head Island, South Carolina, Stany Zjednoczone, 29926
- The Radiation Oncology Center-Hilton Head/Bluffton
-
Seneca, South Carolina, Stany Zjednoczone, 29672
- Prisma Health Cancer Institute - Seneca
-
-
South Dakota
-
Rapid City, South Dakota, Stany Zjednoczone, 57701
- Rapid City Regional Hospital
-
-
Tennessee
-
Germantown, Tennessee, Stany Zjednoczone, 38138
- The West Clinic - Wolf River
-
Nashville, Tennessee, Stany Zjednoczone, 37232
- Vanderbilt University/Ingram Cancer Center
-
-
Texas
-
Dallas, Texas, Stany Zjednoczone, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
San Antonio, Texas, Stany Zjednoczone, 78229
- University of Texas Health Science Center at San Antonio
-
San Antonio, Texas, Stany Zjednoczone, 78229
- Audie L Murphy VA Hospital
-
-
Utah
-
American Fork, Utah, Stany Zjednoczone, 84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City, Utah, Stany Zjednoczone, 84720
- Sandra L Maxwell Cancer Center
-
Farmington, Utah, Stany Zjednoczone, 84025
- Farmington Health Center
-
Logan, Utah, Stany Zjednoczone, 84321
- Logan Regional Hospital
-
Murray, Utah, Stany Zjednoczone, 84107
- Intermountain Medical Center
-
Ogden, Utah, Stany Zjednoczone, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, Stany Zjednoczone, 84604
- Utah Valley Regional Medical Center
-
Riverton, Utah, Stany Zjednoczone, 84065
- Riverton Hospital
-
Salt Lake City, Utah, Stany Zjednoczone, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Stany Zjednoczone, 84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, Stany Zjednoczone, 84143
- LDS Hospital
-
St. George, Utah, Stany Zjednoczone, 84770
- Saint George Regional Medical Center
-
-
Vermont
-
Bennington, Vermont, Stany Zjednoczone, 05201
- Southwestern Vermont Medical Center
-
Berlin Corners, Vermont, Stany Zjednoczone, 05602
- Central Vermont Medical Center/National Life Cancer Treatment
-
Burlington, Vermont, Stany Zjednoczone, 05401
- University of Vermont Medical Center
-
Burlington, Vermont, Stany Zjednoczone, 05405
- University of Vermont and State Agricultural College
-
Saint Johnsbury, Vermont, Stany Zjednoczone, 05819
- Dartmouth Cancer Center - North
-
-
Virginia
-
Portsmouth, Virginia, Stany Zjednoczone, 23708-2197
- Naval Medical Center - Portsmouth
-
Richmond, Virginia, Stany Zjednoczone, 23249
- Hunter Holmes McGuire Veterans Administration Medical Center
-
-
Washington
-
Bellingham, Washington, Stany Zjednoczone, 98225
- PeaceHealth Saint Joseph Medical Center
-
Vancouver, Washington, Stany Zjednoczone, 98686
- Legacy Salmon Creek Hospital
-
Walla Walla, Washington, Stany Zjednoczone, 99362
- Providence Saint Mary Regional Cancer Center
-
-
West Virginia
-
Morgantown, West Virginia, Stany Zjednoczone, 26506
- West Virginia University Healthcare
-
Parkersburg, West Virginia, Stany Zjednoczone, 26101
- Camden Clark Medical Center
-
-
Wisconsin
-
Eau Claire, Wisconsin, Stany Zjednoczone, 54701
- Marshfield Medical Center-EC Cancer Center
-
Grafton, Wisconsin, Stany Zjednoczone, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, Stany Zjednoczone, 54311
- Aurora BayCare Medical Center
-
Kenosha, Wisconsin, Stany Zjednoczone, 53142
- Aurora Cancer Care-Kenosha South
-
Marshfield, Wisconsin, Stany Zjednoczone, 54449
- Marshfield Medical Center-Marshfield
-
Menomonee Falls, Wisconsin, Stany Zjednoczone, 53051
- Froedtert Menomonee Falls Hospital
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53295
- Zablocki Veterans Administration Medical Center
-
Minocqua, Wisconsin, Stany Zjednoczone, 54548
- Marshfield Medical Center - Minocqua
-
New Richmond, Wisconsin, Stany Zjednoczone, 54017
- Cancer Center of Western Wisconsin
-
Oshkosh, Wisconsin, Stany Zjednoczone, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Rice Lake, Wisconsin, Stany Zjednoczone, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Stany Zjednoczone, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Stevens Point, Wisconsin, Stany Zjednoczone, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Summit, Wisconsin, Stany Zjednoczone, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, Stany Zjednoczone, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
West Allis, Wisconsin, Stany Zjednoczone, 53227
- Aurora West Allis Medical Center
-
West Bend, Wisconsin, Stany Zjednoczone, 53095
- Froedtert West Bend Hospital/Kraemer Cancer Center
-
Weston, Wisconsin, Stany Zjednoczone, 54476
- Marshfield Medical Center - Weston
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
-
Pathologically (histologically) proven diagnosis of prostate adenocarcinoma; prostatectomy must have been performed within 10 years prior to Step 1 registration and any type of radical prostatectomy is permitted, including retropubic, perineal, laparoscopic or robotically assisted
-
Post-prostatectomy patients with a detectable serum PSA (>= 0.1, but =< 1.0 ng/mL) at study entry (within 90 days of Step 1 registration) and at least one of the following:
-
Gleason score 7-10 (International Society of Urological Pathology [ISUP] grade group 2 to 5)
-
ISUP grade group:
- Grade group 1 = Gleason score =< 6,
- Grade group 2 = Gleason score 3 + 4 = 7,
- Grade group 3 = Gleason score 4 + 3 = 7,
- Grade group 4 = Gleason score 8,
- Grade group 5 = Gleason scores 9 and 10
-
>= T3a disease
-
Persistent elevation of PSA after prostatectomy measured within 90 days after surgery (PSA never became undetectable) of > 0.04 but < 0.2 ng/mL (PSA nadir)
-
-
pN0 or pNx
-
History/physical examination within 90 days prior to Step 1 registration
-
Karnofsky performance status of 70-100 within 90 days prior to Step 1 registration
-
Surgical formalin-fixed paraffin-embedded (FFPE) specimen must be available for submission to GenomeDx for genomic analysis on Decipher GRID platform; Note: if Decipher results have already been obtained, in lieu of tissue, results must be submitted to GenomeDx for validation and for GenomeDx to provide the subtyping needed for stratification
-
Prior androgen deprivation therapy (luteinizing hormone-releasing hormone [LHRH] agonist and/or non-steroidal anti-androgen) is allowed if discontinued at least 90 days prior to Step 1 registration and given for =< 90 days duration
- For example: patients on prior LHRH analogs (post-prostatectomy), the discontinuation date should be calculated based on the expected duration of the sustained release injection, not simply the injection date of the drug; for instance, if a 22.5 mg sustained release dose of leuprolide acetate is given (3 month duration), then the expected duration of such a dose would be 90 days after the injection date; for a 7.5 mg leuprolide (1 month duration), the discontinuation date would be 30 days after the injection date
- Please note: finasteride or dutasteride must be stopped before treatment starts but prior usage will not affect eligibility
-
Hemoglobin >= 9.0 g/dL, independent of transfusion and/or growth factors within 90 days prior to Step 1 registration
-
Platelet count >= 100,000 x 10^9/uL independent of transfusion and/or growth factors within 90 days prior to Step 1 registration
-
Serum albumin >= 3.0 g/dL within 90 days prior to Step 1 registration
-
Glomerular filtration rate (GFR) >= 35 mL/min estimated by Cockcroft-Gault or measured directly by 24 hour urine creatinine within 90 days prior to Step 1 registration
-
Serum total bilirubin =< 1.5 x upper limit of normal (ULN) (Note: in subjects with Gilbert's syndrome, if total bilirubin is > 1.5 x ULN, measure direct and indirect bilirubin and if direct bilirubin is =< 1.5 x ULN, subject is eligible) within 90 days prior to Step 1 registration
-
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 2.5 x ULN within 90 days prior to Step 1 registration
-
Testosterone > 50 ng/dL within 90 days prior to Step 1 registration
-
Concomitant medications known to lower the seizure threshold discontinued or substituted at least 4 weeks (30 days) prior to Step 1 registration
-
The patient must agree to use a condom (even men with vasectomies) and another effective method of birth control if he is having sex with a woman of childbearing potential or agree to use a condom if he is having sex with a woman who is pregnant while on study drug and for 3 months following the last dose of study drug
-
The patient must agree not to donate sperm during the study treatment and for 3 months after receiving the last dose of study drug
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Exclusion Criteria:
-
PRIOR TO STEP 1 REGISTRATION:
-
Definitive clinical, radiologic, or pathologic evidence of metastatic disease (M1) or lymph node involvement (N1)
-
Prior invasive malignancy (except non-melanomatous skin cancer, carcinoma in situ of the male breast, penis, oral cavity, or stage Ta of the bladder, or stage I completely resected melanoma) unless disease free for a minimum of 2 years
-
Prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a different cancer is allowable
-
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
-
History of any of the following:
- Seizure or known condition that may pre-dispose to seizure (e.g. prior stroke within 1 year prior to Step 1 registration)
- History of documented inflammatory bowel disease
- Transmural myocardial infarction within the last 4 months prior to Step 1 registration
- Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months prior to Step 1 registration
- History of any condition that in the opinion of the investigator, would preclude participation in this study
-
Current evidence of any of the following:
- Known gastrointestinal disorder affecting absorption of oral medications
- Active uncontrolled infection (e.g., human immunodeficiency virus [HIV] or viral hepatitis)
- Uncontrolled hypertension
- Any current condition that in the opinion of the investigator, would preclude participation in this study
-
Prior whole gland ablative therapy (i.e. cryoablation or high intensity focused ultrasound [HIFU]) for prostate cancer is not allowed
-
HIV positive with CD4 count < 200 cells/microliter within 30 days prior to registration
-
HIV patients under treatment with highly active antiretroviral therapy (HAART) within 30 days prior to registration regardless of CD4 count; (Note: HIV testing is not required for eligibility for this protocol as it is self-reported; this exclusion criterion is necessary because the treatments involved in this protocol may be immunosuppressive and/or interact with HAART)
-
Patients must not plan to participate in any other clinical trials while receiving treatment on this study or being followed post-protocol therapy
-
PRIOR TO STEP 2 REGISTRATION:
-
For patients who have not undergone prior Decipher analysis, submission of the specimen to GenomeDx should be as soon as possible after study registration (Step 1) as these results can take up 21 days after the specimen is received at GenomeDx; Step 2 registration must occur within 6 weeks (42 days) of Step 1 registration; if Decipher results have already been obtained, in lieu of tissue, results must be submitted to GenomeDx for validation
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Liczba ramion
Broń i interwencje
Grupa uczestników / ArmGrupa uczestników / Arm |
Interwencja / LeczenieInterwencja / Leczenie |
|---|---|
|
Aktywny komparator: Arm 1 (radiation therapy, placebo)
Patients undergo external beam radiation therapy on day 1 for 7-8 weeks. Beginning on day of radiation therapy, patients receive placebo PO QD on days 1-30. Treatment repeats every 30 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity. |
Given PO Undergo external beam radiation therapy
Inne nazwy:
|
|
Eksperymentalny: Arm 2 (radiation therapy, apalutamide)
Patients undergo external beam radiation therapy on day 1 for 7-8 weeks. Beginning on day of radiation therapy, patients receive apalutamide PO QD on days 1-30. Treatment repeats every 30 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity. |
Undergo external beam radiation therapy
Inne nazwy:
Given PO
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Percentage of Participants Alive Without Biochemical Progression (Biochemical Progression-free Survival)
Ramy czasowe: From randomization to biochemical progression or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
Biochemical progression is defined as the first occurrence of the following:
|
From randomization to biochemical progression or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
Miary wyników drugorzędnych
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Proportion of Participants With Undetectable PSA (< 0.1) and Non-castrate Testosterone (≥ 50 ng/dl) at One and Three Years
Ramy czasowe: One and three years
|
One and three years
|
|
|
Percentage of Participants Alive (Overall Survival)
Ramy czasowe: From randomization to death or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
Survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis. |
From randomization to death or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
|
Percentage of Participants Who Have Died Due to Prostate Cancer (Cancer-specific Mortality (CSM))
Ramy czasowe: From the date of randomization to the date of death due to prostate cancer or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
Prostate cancer death rates were estimated using the cumulative incidence method in which death from other causes is treated as a competing risk and alive patients are censored. |
From the date of randomization to the date of death due to prostate cancer or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
|
Percentage of Participants Alive Without Distant Metastases (Metastasis-free Survival (MFS))
Ramy czasowe: From randomization to date of first distant metastasis or death, or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
Distant metastases are defined as clinical or radiographic appearance of disseminated disease. MFS rates are estimated using the Kaplan-Meier method, censoring participants alive without metastases at time of analysis. |
From randomization to date of first distant metastasis or death, or last follow-up if alive. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
|
Percentage of Participants With Distant Metastasis
Ramy czasowe: From randomization to date of first distant metastasis or death, or last follow-up if alive at time of analysis. Median follow-up at time of analysis was 5.0 years. Five-year rates are presented.
|
Distant metastases are defined as clinical or radiographic appearance of disseminated disease. Distant metastasis rates are estimated using the cumulative incidence method in which death is treated as competing risk and participants alive without distant metastases are censored at last known follow-up. |
From randomization to date of first distant metastasis or death, or last follow-up if alive at time of analysis. Median follow-up at time of analysis was 5.0 years. Five-year rates are presented.
|
|
Percentage of Participants Wtih Local-regional Progression
Ramy czasowe: From randomization to date of first local or regional recurrence or death, or last follow-up if alive at time of analysis. Median follow-up at time of analysis was 5.0 years. Five-year rates are presented.
|
Local-regional progression is defined as recurrence within the pelvis including lymph nodes below the iliac bifurcation. Local-regional progression rates are estimated using the cumulative incidence method in which death is treated as competing risk and participants alive without local-regional progression are censored at last known follow-up. |
From randomization to date of first local or regional recurrence or death, or last follow-up if alive at time of analysis. Median follow-up at time of analysis was 5.0 years. Five-year rates are presented.
|
|
PSA Nadir During First Year of Treatment and Prior to Initiation of Any Hormonal Salvage Therapy
Ramy czasowe: First year of treatment
|
Will be compared between the two groups using a two-sample t-test. |
First year of treatment
|
|
Percentage of Participants That Started Salvage Hormonal Therapy
Ramy czasowe: From randomization to initiation of salvage hormonal therapy or death, whichever occurs first, or last follow-up if alive at time of analysis. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
Initiation of salvage hormone therapy (LHRH analogues or non-study anti-androgens) that occurs after completion of SRT. Salvage hormonal therapy rates are estimated using the cumulative incidence method in which death is treated as competing risk and participants alive who have not started salvage hormonal therapy are censored at last known follow-up. |
From randomization to initiation of salvage hormonal therapy or death, whichever occurs first, or last follow-up if alive at time of analysis. Median follow-up at time of analysis among surviving patients was 5.0 years. Five-year rates are presented.
|
|
Number of Participants With Grade 3+ Adverse Events Occurring Within 30 Days After the Completion of RT
Ramy czasowe: Up to 30 days after radiation therapy, which lasts approximately 7-8 weeks from treatment start.
|
National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 grades adverse event severity as follows: 1 = mild, 2 = moderate, 3 = severe, 4 = life-threatening, 5 = death related to adverse event. Summary data is provided in this outcome measure; see Adverse Events Module for specific adverse event data. |
Up to 30 days after radiation therapy, which lasts approximately 7-8 weeks from treatment start.
|
|
Number of Participants With Grade 3+ Adverse Events Occurring More Than 30 Days After the Completion of Radiation Therapy
Ramy czasowe: From the end of radiation therapy (approximately 7-8 weeks from treatment start) to last follow-up. Median follow-up at time of analysis among surviving patients was 5.0 years.
|
National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 grades adverse event severity as follows: 1 = mild, 2 = moderate, 3 = severe, 4 = life-threatening, 5 = death related to adverse event. Summary data is provided in this outcome measure; see Adverse Events Module for specific adverse event data. |
From the end of radiation therapy (approximately 7-8 weeks from treatment start) to last follow-up. Median follow-up at time of analysis among surviving patients was 5.0 years.
|
|
Testosterone Levels
Ramy czasowe: 3, 6, 9, and 12 months
|
Testosterone levels will be reported at this time points. |
3, 6, 9, and 12 months
|
|
Number of Participants With Patient Reported Outcomes-Common Terminology Criteria for Adverse Events (PRO-CTCAE) Severity Score ≥ 3 (or Present) Occurring Within 30 Days After the Completion of RT
Ramy czasowe: Up to 5 years
|
PRO-CTCAE is a patient-reported outcome (PRO) measurement system developed to evaluate symptomatic toxicity in patients on cancer clinical trials, asking the patient about experience over the last seven days. Scores may reflect worst severity of the symptom (0=None, 1=Mild, 2=Moderate, 3=Severe, and 4=Very severe), frequency of the symptom (0=Never, 1=Rarely, 2=Occasionally, 3=Frequently, 4=Almost constantly), or the symptom's interference with one's "usual or daily activities" (0=Not at all, 1=A little bit, 2=Somewhat, 3=Quite a bit, 4=Very much). The symptom row title will indicate "Severity", "Frequency", or "Interference". All scores are compared between arms; statistical analysis results are entered for p-values < 0.05. |
Up to 5 years
|
|
Number of Participants With Patient Reported Outcomes-Common Terminology Criteria for Adverse Events (PRO-CTCAE) Severity Score ≥ 3 (or Present) Occurring More Thant 30 Days After the Completion of RT
Ramy czasowe: From the end of radiation therapy (approximately 7-8 weeks from treatment start) to two years.
|
PRO-CTCAE is a patient-reported outcome (PRO) measurement system developed to evaluate symptomatic toxicity in patients on cancer clinical trials, asking the patient about experience over the last seven days. Scores may reflect worst severity of the symptom (0=None, 1=Mild, 2=Moderate, 3=Severe, and 4=Very severe), frequency of the symptom (0=Never, 1=Rarely, 2=Occasionally, 3=Frequently, 4=Almost constantly), or the symptom's interference with one's "usual or daily activities" (0=Not at all, 1=A little bit, 2=Somewhat, 3=Quite a bit, 4=Very much). The symptom row title will indicate "Severity", "Frequency", or "Interference". All scores are compared between arms; statistical analysis results are entered for p-values < 0.05. |
From the end of radiation therapy (approximately 7-8 weeks from treatment start) to two years.
|
Współpracownicy i badacze
Sponsor
Sponsor
Współpracownicy
Współpracownicy
Śledczy
Śledczy
- Główny śledczy: Felix Y Feng, NRG Oncology
Publikacje i pomocne linki
Publikacje ogólne
- Morgan TM, Boorjian SA, Buyyounouski MK, Chapin BF, Chen DYT, Cheng HH, Chou R, Jacene HA, Kamran SC, Kim SK, Kirkby E, Luckenbaugh AN, Nathanson BJ, Nyame YA, Posadas EM, Tran PT, Chen RC. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy. J Urol. 2024 Apr;211(4):518-525. doi: 10.1097/JU.0000000000003891. Epub 2024 Feb 29.
- Morgan TM, Boorjian SA, Buyyounouski MK, Chapin BF, Chen DYT, Cheng HH, Chou R, Jacene HA, Kamran SC, Kim SK, Kirkby E, Luckenbaugh AN, Nathanson BJ, Nyame YA, Posadas EM, Tran PT, Chen RC. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions. J Urol. 2024 Apr;211(4):526-532. doi: 10.1097/JU.0000000000003890. Epub 2024 Feb 29.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Zakończenie podstawowe
Ukończenie studiów (Szacowany)
Ukończenie studiów
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Pierwszy wysłany
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia wysłana aktualizacja
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Choroby układu moczowo-płciowego
- Choroby narządów płciowych
- Nowotwory narządów płciowych, mężczyzna
- Nowotwory układu moczowo-płciowego
- Nowotwory według lokalizacji
- Nowotwory
- Choroby narządów płciowych, mężczyzna
- Choroby prostaty
- Choroby układu moczowo-płciowego u mężczyzn
- Nowotwory prostaty
- Zjawiska fizyczne
- Organizacje
- Ekonomia i organizacje opieki zdrowotnej
- Promieniowanie
- Kongresy jako temat
- apalutamid
Inne numery identyfikacyjne badania
Inne numery identyfikacyjne badania
- NRG-GU006
- U10CA180868 (Grant/umowa NIH USA)
- NRG-GU006 (Inny identyfikator: CTEP)
- NCI-2017-01268 (Identyfikator rejestru: CTRP (Clinical Trial Reporting Program))
- NRG-GU006 (Inny identyfikator: NRG Oncology)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .